Jason Karlawish
speaker
1,378 appearances
5 recordings
1 series
first heard Feb 2021
last heard Dec 2023
Jason Karlawish’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
is something that we can be part of and inform and in and improve.
the way these diseases are diagnosed and treated.
Uh rather than be on the outside saying
there's not enough benefit or, you know, amyloid isn't the only cause, so I'm not gonna pay attention to these data.
I just don't think that that's clinically responsible and scientifically responsible for us anymore as a field.
screening, no, I I think geriatricians should be prepared geriatricians should be ready to practice for patients who have MCI or mild stage dementia that looks like the Alzheimer's phenotype to be comfortable with ordering biomarker test tests, particularly amyloid, to uh to to confirm the person has amyloid, likely therefore has Alzheimer's.
a and engage in a conversation about this drug.
I think they could should be comfortable with, I don't have to have an infusion center, but you know, following up uh the the the next steps in terms of uh uh MRI imaging, et cetera.
I think that these drugs are probably to be prescribed in what we're very good at, multidisciplinary teams, you know, where uh uh once the drug is started, uh uh our colleagues in the in our practice can help with monitoring response, such as uh paraprofessionals.
But yeah, I think we should be comfortable uh being prescribers for these drugs in a responsible and reasonable way.
Absolutely.
Yeah.
I think F F DA should approve this drug, uh full approval.
Uh I I I think we should stop this conditional approval nonsense.
Uh it it needs review for full approval and I think it based on the data out there, it should get full approval.
I think FDA should approve it though, with a risk evaluation and mitigation strategy attached to it or REMS.
Ah, we won't get fooled again, right, Ken?
No, I mean
Thanks a lot, man.
The JerryPow podcast is brought to you by Artstone Foundation, improving the health and well-being of older Californians and their caregivers.
Showing 761–780 of 1,378 · page 39 of 69
← Previous
Next →